Login / Signup

Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial.

Rahul AggarwalDeepak L BhattMichael SzarekLawrence A LeiterChristopher P CannonRenato D LopesMichael J DaviesPhillip BanksBertram PittPh Gabriel Steg
Published in: European journal of heart failure (2024)
Keyphrases
  • chronic kidney disease
  • end stage renal disease